{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:18:44Z","timestamp":1762899524875,"version":"3.37.3"},"reference-count":110,"publisher":"Tech Science Press","issue":"1","license":[{"start":{"date-parts":[[2017,12,11]],"date-time":"2017-12-11T00:00:00Z","timestamp":1512950400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,12,11]],"date-time":"2017-12-11T00:00:00Z","timestamp":1512950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Congenital Heart Disease"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1111\/chd.12564","type":"journal-article","created":{"date-parts":[[2017,12,11]],"date-time":"2017-12-11T05:19:05Z","timestamp":1512969545000},"page":"5-15","source":"Crossref","is-referenced-by-count":30,"title":["State of the art review: Chemotherapy-induced cardiotoxicity in children"],"prefix":"10.32604","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3859-1294","authenticated-orcid":false,"given":"Robert W.","family":"Loar","sequence":"first","affiliation":[{"name":"Pediatric Cardiology; Texas Children's Hospital\/Baylor College of Medicine; Houston Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cory V.","family":"Noel","sequence":"additional","affiliation":[{"name":"Pediatric Cardiology; Texas Children's Hospital\/Baylor College of Medicine; Houston Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hari","family":"Tunuguntla","sequence":"additional","affiliation":[{"name":"Pediatric Cardiology; Texas Children's Hospital\/Baylor College of Medicine; Houston Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John L.","family":"Colquitt","sequence":"additional","affiliation":[{"name":"Pediatric Cardiology; Texas Children's Hospital\/Baylor College of Medicine; Houston Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo H.","family":"Pignatelli","sequence":"additional","affiliation":[{"name":"Pediatric Cardiology; Texas Children's Hospital\/Baylor College of Medicine; Houston Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"17807","published-online":{"date-parts":[[2017,12,11]]},"reference":[{"volume-title":"SEER Cancer Statistics Review, 1975-2013","year":"2016","author":"Howlader","key":"10.1111\/chd.12564-BIB0001|chd12564-cit-0002"},{"issue":"4","key":"10.1111\/chd.12564-BIB0002|chd12564-cit-0003","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1158\/1055-9965.EPI-14-1418","article-title":"Survivors of childhood cancer in the United States: prevalence and burden of morbidity","volume":"24","author":"Phillips","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"issue":"19","key":"10.1111\/chd.12564-BIB0003|chd12564-cit-0004","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1093\/jnci\/djn310","article-title":"Cause-specific late mortality among 5-year survivors of childhood cancer: the childhood cancer survivor study","volume":"100","author":"Mertens","year":"2008","journal-title":"J Natl Cancer Inst."},{"issue":"13","key":"10.1111\/chd.12564-BIB0004|chd12564-cit-0005","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1200\/JCO.2001.19.13.3163","article-title":"Late mortality experience in five-year survivors of childhood and adolescent cancer: the childhood cancer survivor study","volume":"19","author":"Mertens","year":"2001","journal-title":"J Clin Oncol."},{"key":"10.1111\/chd.12564-BIB0005|chd12564-cit-0006","doi-asserted-by":"crossref","first-page":"b4606","DOI":"10.1136\/bmj.b4606","article-title":"Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the childhood cancer survivor study cohort","volume":"339","author":"Mulrooney","year":"2009","journal-title":"BMJ."},{"key":"10.1111\/chd.12564-BIB0006|chd12564-cit-0007","first-page":"724","article-title":"A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin","volume":"57","author":"Gewirt","year":"1999","journal-title":"Biochem Pharmacol."},{"issue":"2","key":"10.1111\/chd.12564-BIB0007|chd12564-cit-0008","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1124\/pr.56.2.6","article-title":"Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity","volume":"56","author":"Minotti","year":"2004","journal-title":"Pharmacol Rev."},{"issue":"11","key":"10.1111\/chd.12564-BIB0008|chd12564-cit-0009","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/nm.2919","article-title":"Identification of the molecular basis of doxorubicin-induced cardiotoxicity","volume":"18","author":"Zhang","year":"2012","journal-title":"Nat Med."},{"issue":"2","key":"10.1111\/chd.12564-BIB0009|chd12564-cit-0010","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.pcad.2010.06.007","article-title":"Mechanisms of anthracycline cardiac injury: can we identify strategies for cardioprotection?","volume":"53","author":"Sawyer","year":"2010","journal-title":"Prog Cardiovasc Dis."},{"issue":"8","key":"10.1111\/chd.12564-BIB0010|chd12564-cit-0011","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1517\/14656566.8.8.1039","article-title":"Anthracycline-induced cardiotoxicity: course, pathophysiology, prevention, and management","volume":"8","author":"Barry","year":"2007","journal-title":"Expert Opin Pharmacol."},{"issue":"1","key":"10.1111\/chd.12564-BIB0011|chd12564-cit-0012","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S1734-1140(09)70018-0","article-title":"Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron","volume":"61","author":"\u0160im\u016fnek","year":"2009","journal-title":"Pharmacol Rep."},{"issue":"1","key":"10.1111\/chd.12564-BIB0012|chd12564-cit-0013","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1040-8428(97)10007-5","article-title":"Anthracycline-induced cardiotoxicity in children and young adults","volume":"27","author":"Giantris","year":"1998","journal-title":"Crit Rev Oncol Hematol."},{"issue":"5","key":"10.1111\/chd.12564-BIB0013|chd12564-cit-0014","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2141.2005.05759.x","article-title":"Protecting against anthracycline-induced myocardial damage: a review of the most promising strategies","volume":"131","author":"Wouters","year":"2005","journal-title":"Br J Haematol."},{"issue":"1","key":"10.1111\/chd.12564-BIB0014|chd12564-cit-0015","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/jpet.110.165860","article-title":"Pharmacological foundations of cardio-oncology","volume":"334","author":"Minotti","year":"2010","journal-title":"J Pharmacol Exp Ther."},{"issue":"2","key":"10.1111\/chd.12564-BIB0015|chd12564-cit-0016","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/1097-0142(197308)32:2<302::AID-CNCR2820320205>3.0.CO;2-2","article-title":"A clinicopathologic analysis of adriamycin cardiotoxicity","volume":"32","author":"Lefrak","year":"1973","journal-title":"Cancer."},{"issue":"5","key":"10.1111\/chd.12564-BIB0016|chd12564-cit-0017","doi-asserted-by":"crossref","first-page":"710","DOI":"10.7326\/0003-4819-91-5-710","article-title":"Risk factors for doxorubicin-induced congestive heart failure","volume":"91","author":"Von Hoff","year":"1979","journal-title":"Ann Intern Med."},{"issue":"6","key":"10.1111\/chd.12564-BIB0017|chd12564-cit-0018","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM197902083000603","article-title":"Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography","volume":"300","author":"Alexander","year":"1979","journal-title":"N Engl J Med."},{"issue":"12","key":"10.1111\/chd.12564-BIB0018|chd12564-cit-0019","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1002\/1097-0142(19850615)55:12<2761::AID-CNCR2820551206>3.0.CO;2-P","article-title":"Early and delayed clinical cardiotoxicity of doxorubicin","volume":"55","author":"Buzdar","year":"1985","journal-title":"Cancer."},{"issue":"11","key":"10.1111\/chd.12564-BIB0019|chd12564-cit-0020","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1002\/cncr.11407","article-title":"Congestive heart failure in patients treated with doxorubicin","volume":"97","author":"Swain","year":"2003","journal-title":"Cancer."},{"issue":"9","key":"10.1111\/chd.12564-BIB0020|chd12564-cit-0021","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.healun.2003.08.014","article-title":"Pediatric heart transplantation for anthracycline cardiomyopathy: cancer recurrence is rare","volume":"23","author":"Ward","year":"2004","journal-title":"J Heart Lung Transplant."},{"issue":"12","key":"10.1111\/chd.12564-BIB0021|chd12564-cit-0022","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1200\/JCO.2005.12.121","article-title":"Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia","volume":"23","author":"Lipshultz","year":"2005","journal-title":"J Clin Oncol."},{"key":"10.1111\/chd.12564-BIB0022|chd12564-cit-0023","first-page":"865","article-title":"Anthracycline cardiomyopathy monitored by morphologic changes","volume":"62","author":"Billingham","year":"1978","journal-title":"Cancer Treat Rep."},{"issue":"2","key":"10.1111\/chd.12564-BIB0023|chd12564-cit-0024","doi-asserted-by":"crossref","first-page":"168","DOI":"10.7326\/0003-4819-88-2-168","article-title":"Doxorubicin cardiomyopathy evaluation by phonocardiography endomyocardial biopsy and cardiac catheterization","volume":"88","author":"Bristow","year":"1978","journal-title":"Ann Intern Med."},{"issue":"13","key":"10.1111\/chd.12564-BIB0024|chd12564-cit-0025","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1200\/JCO.2010.33.4730","article-title":"High risk of symptomatic cardiac events in childhood cancer survivors","volume":"30","author":"Pal","year":"2012","journal-title":"J Clin Oncol."},{"key":"10.1111\/chd.12564-BIB0025|chd12564-cit-0026","first-page":"945","article-title":"Asymptomatic cardiac disease following mediastinal irradiation","volume":"63","author":"Heidenreich","year":"2014","journal-title":"J Am Coll Cardiol."},{"issue":"21","key":"10.1111\/chd.12564-BIB0026|chd12564-cit-0027","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1001\/jama.290.21.2831","article-title":"Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy","volume":"290","author":"Hull","year":"2003","journal-title":"JAMA."},{"issue":"8","key":"10.1111\/chd.12564-BIB0027|chd12564-cit-0028","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1200\/JCO.2008.20.2267","article-title":"Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancer","volume":"28","author":"Tukenova","year":"2010","journal-title":"J Clin Oncol."},{"issue":"1","key":"10.1111\/chd.12564-BIB0028|chd12564-cit-0029","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/HCO.0000000000000034","article-title":"Anthracycline-related cardiotoxicity in childhood cancer survivors","volume":"29","author":"Lipshultz","year":"2014","journal-title":"Curr Opin Cardiol."},{"issue":"19","key":"10.1111\/chd.12564-BIB0029|chd12564-cit-0030","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1002\/cncr.28256","article-title":"Impact of hemochromatosis gene mutations on cardiac status in doxorubicin-treated survivors of childhood high-risk leukemia","volume":"119","author":"Lipshultz","year":"2013","journal-title":"Cancer."},{"issue":"24","key":"10.1111\/chd.12564-BIB0030|chd12564-cit-0031","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1161\/CIRCULATIONAHA.105.576850","article-title":"NADPH oxidase and multidrug resistance protein polymorphisms are associated with doxorubicin-induced cardiotoxicity","volume":"112","author":"Wojnowski","year":"2005","journal-title":"Circulation."},{"issue":"1","key":"10.1111\/chd.12564-BIB0031|chd12564-cit-0032","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1042\/CBI20110264","article-title":"ABCC1 polymorphisms in anthracycline-induced cardiotoxicity in childhood acute lymphoblastic leukemia","volume":"36","author":"Semsei","year":"2012","journal-title":"Cell Biol Int."},{"issue":"13","key":"10.1111\/chd.12564-BIB0032|chd12564-cit-0033","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1200\/JCO.2011.34.8987","article-title":"Anthracycline-related cardiomyopathy after childhood cancer: role of polymorphisms in carbonyl reductase genes-a report from the Children's Oncology Group","volume":"30","author":"Blanco","year":"2012","journal-title":"J Clin Oncol."},{"issue":"13","key":"10.1111\/chd.12564-BIB0033|chd12564-cit-0034","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1200\/JCO.2010.34.3467","article-title":"Pharmacogenetic prediction of anthracycline-induced cardiotoxicity in children","volume":"30","author":"Visscher","year":"2012","journal-title":"J Clin Oncol."},{"key":"10.1111\/chd.12564-BIB0034|chd12564-cit-0035","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/bjh.12516","article-title":"Genetic susceptibility to anthracycline-related congestive heart failure in survivors of haematopoietic cell transplantation","volume":"163","author":"Armenian","year":"2013","journal-title":"Br J Haematol."},{"issue":"3","key":"10.1111\/chd.12564-BIB0035|chd12564-cit-0036","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2217\/pgs.15.162","article-title":"Evidence for association of SNPs in ABC1 and CBR3, but not RAC2, NCF4, SLC28A3 or TOP2b, with chronic cardiotoxicity in a cohort of breast cancer patients treated with anthracyclines","volume":"17","author":"Hertz","year":"2016","journal-title":"Pharmacogenetics."},{"issue":"10","key":"10.1111\/chd.12564-BIB0036|chd12564-cit-0037","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1080\/10428190903177212","article-title":"Influence of polymorphism in candidate genes on late cardiac damage in patients treated due to acute leukemia in childhood","volume":"50","author":"Raji\u0107","year":"2009","journal-title":"Leuk Lymphoma."},{"issue":"7","key":"10.1111\/chd.12564-BIB0037|chd12564-cit-0038","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1200\/JCO.2013.50.3557","article-title":"Hyaluronan synthase 3 variant and anthracycline-related cardiomyopathy: a report from the Children's Oncology Group","volume":"32","author":"Wang","year":"2014","journal-title":"J Clin Oncol."},{"issue":"3","key":"10.1111\/chd.12564-BIB0038|chd12564-cit-0039","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/bcp.13008","article-title":"CPNDS Clinical Practice Recommendations Group. Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity","volume":"82","author":"Aminkeng","year":"2016","journal-title":"Br J Clin Pharmacol."},{"key":"10.1111\/chd.12564-BIB0039|chd12564-cit-0040","first-page":"CD005006","article-title":"Different anthracycline derivatives for reducing cardiotoxicity in cancer patients","volume":"5","author":"Dalen","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1111\/chd.12564-BIB0040|chd12564-cit-0041","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/pbc.20352","article-title":"Pathophysiology of anthracycline- and radiation-associated cardiomyopathies: implications for screening and prevention","volume":"44","author":"Adams","year":"2005","journal-title":"Pediatr Blood Cancer."},{"issue":"8","key":"10.1111\/chd.12564-BIB0041|chd12564-cit-0042","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1517\/14656566.8.8.1039","article-title":"Anthracycline-induced cardiotoxicity: course pathophysiology, prevention, and management","volume":"8","author":"Barry","year":"2007","journal-title":"Expert Opin Pharmacother."},{"issue":"12","key":"10.1111\/chd.12564-BIB0042|chd12564-cit-0043","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJM199103213241205","article-title":"Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood","volume":"324","author":"Lipshultz","year":"1991","journal-title":"N Engl J Med."},{"issue":"23","key":"10.1111\/chd.12564-BIB0043|chd12564-cit-0044","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1161\/CIRCULATIONAHA.112.100560","article-title":"Cancer therapy induced cardiac toxicity in early breast cancer: addressing the unresolved issues","volume":"126","author":"Khouri","year":"2012","journal-title":"Circulation."},{"issue":"10","key":"10.1111\/chd.12564-BIB0044|chd12564-cit-0045","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/ehjci\/jeu192","article-title":"Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"15","author":"Plana","year":"2014","journal-title":"Eur Heart J Cardiovasc Imag."},{"issue":"2","key":"10.1111\/chd.12564-BIB0045|chd12564-cit-0046","doi-asserted-by":"crossref","first-page":"93","DOI":"10.7326\/M15-0424","article-title":"Cardiac outcomes in adult survivors of childhood cancer exposed to cardiotoxic therapy: a cross-sectional study","volume":"164","author":"Mulrooney","year":"2016","journal-title":"Ann Intern Med."},{"issue":"22","key":"10.1111\/chd.12564-BIB0046|chd12564-cit-0047","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.114.013777","article-title":"Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy","volume":"131","author":"Cardinale","year":"2015","journal-title":"Circulation."},{"issue":"3","key":"10.1111\/chd.12564-BIB0047|chd12564-cit-0048","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1016\/S1470-2045(14)70409-7","article-title":"Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group","volume":"16","author":"Armenian","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1111\/chd.12564-BIB0048|chd12564-cit-0049","unstructured":"Children's Oncology Group"},{"issue":"6","key":"10.1111\/chd.12564-BIB0049|chd12564-cit-0050","doi-asserted-by":"crossref","first-page":"e26367","DOI":"10.1002\/pbc.26367","article-title":"Yield of screening echocardiograms during pediatric follow-up in survivors treated with anthracyclines and cardiotoxic radiation","volume":"64","author":"Spewak","year":"2017","journal-title":"Pediatr Blood & Cancer."},{"issue":"5","key":"10.1111\/chd.12564-BIB0050|chd12564-cit-0051","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1200\/JCO.2014.56.1373","article-title":"Individual prediction of heart failure among childhood cancer survivors","volume":"33","author":"Chow","year":"2015","journal-title":"J Clin Oncol."},{"issue":"4","key":"10.1111\/chd.12564-BIB0051|chd12564-cit-0052","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s00246-013-0835-9","article-title":"Variability of M-Mode versus two-dimensional echocardiography measurements in children with dilated cardiomyopathy","volume":"35","author":"Lee","year":"2014","journal-title":"Pediatr Cardiol."},{"issue":"2","key":"10.1111\/chd.12564-BIB0052|chd12564-cit-0053","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1161\/CIRCIMAGING.112.000175","article-title":"Interpretation of left ventricular diastolic dysfunction in children with cardiomyopathy by echocardiography: problems and limitations","volume":"6","author":"Dragulescu","year":"2013","journal-title":"Circ Cardiovasc Imaging."},{"key":"10.1111\/chd.12564-BIB0053|chd12564-cit-0054","doi-asserted-by":"crossref","first-page":"e002167","DOI":"10.1161\/CIRCIMAGING.114.002167","article-title":"Reference values for pulse wave Doppler and tissue Doppler imaging in pediatric echocardiography","volume":"8","author":"Dellaire","year":"2015","journal-title":"Circ Cardiovasc Imaging."},{"issue":"1","key":"10.1111\/chd.12564-BIB0054|chd12564-cit-0055","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jacc.2012.09.035","article-title":"Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy","volume":"61","author":"Thavendiranathan","year":"2013","journal-title":"JACC."},{"issue":"23","key":"10.1111\/chd.12564-BIB0055|chd12564-cit-0056","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1200\/JCO.2011.40.3584","article-title":"Screening adult survivors of childhood cancer for cardiomyopathy: comparison of echocardiography and cardiac magnetic resonance imaging","volume":"30","author":"Armstrong","year":"2012","journal-title":"J Clin Oncol."},{"issue":"12","key":"10.1111\/chd.12564-BIB0056|chd12564-cit-0057","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.echo.2005.03.024","article-title":"Two-dimensional strain: a Doppler-independent ultrasound method for quantitation of regional deformation: validation in vitro and in vivo","volume":"18","author":"Korinek","year":"2005","journal-title":"J Am Soc Echocardiogr."},{"issue":"6","key":"10.1111\/chd.12564-BIB0057|chd12564-cit-0058","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.echo.2011.01.021","article-title":"Reference values for myocardial two-dimensional strain echocardiography in a healthy pediatric and young adult cohort","volume":"24","author":"Marcus","year":"2011","journal-title":"J Am Soc Echocardiogr."},{"issue":"11","key":"10.1111\/chd.12564-BIB0058|chd12564-cit-0059","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.echo.2013.07.002","article-title":"Reproducibility of speckle-tracking based strain measures of left ventricular function in a community based study","volume":"26","author":"Cheng","year":"2013","journal-title":"J Am Soc Echocardiogr."},{"issue":"25","key":"10.1111\/chd.12564-BIB0059|chd12564-cit-0060","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1016\/j.jacc.2014.01.073","article-title":"Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review","volume":"63","author":"Thavendiranathan","year":"2014","journal-title":"JACC."},{"issue":"5","key":"10.1111\/chd.12564-BIB0060|chd12564-cit-0061","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1161\/CIRCIMAGING.112.973321","article-title":"Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab","volume":"5","author":"Sawaya","year":"2012","journal-title":"Circ Cardiovasc Imaging."},{"issue":"12","key":"10.1111\/chd.12564-BIB0061|chd12564-cit-0062","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/ejechocard\/jer187","article-title":"Two-dimensional myocardial strain imaging detects change in left ventricular systolic function immediately after anthracycline chemotherapy","volume":"12","author":"Stoodley","year":"2011","journal-title":"Eur J Echocardiogr."},{"issue":"15","key":"10.1111\/chd.12564-BIB0062|chd12564-cit-0063","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1093\/eurheartj\/ehl013","article-title":"Tissue Doppler imaging predicts left ventricular dysfunction and mortality in a murine model of cardiac injury","volume":"27","author":"Neilan","year":"2006","journal-title":"Eur Heart J."},{"issue":"9","key":"10.1111\/chd.12564-BIB0063|chd12564-cit-0064","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/hrt.2009.173997","article-title":"Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study","volume":"96","author":"Ho","year":"2010","journal-title":"Heart."},{"issue":"12","key":"10.1111\/chd.12564-BIB0064|chd12564-cit-0065","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.echo.2007.04.007","article-title":"Myocardial dysfunction late after low-dose anthracycline treatment in asymptomatic pediatric patients","volume":"20","author":"Ganame","year":"2007","journal-title":"J Am Soc Echocardiogr."},{"issue":"5","key":"10.1111\/chd.12564-BIB0065|chd12564-cit-0066","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.echo.2013.02.008","article-title":"Independent and incremental value of deformation indices for prediction of trastuzumab-induced cardiotoxicity","volume":"26","author":"Negishi","year":"2013","journal-title":"J Am Soc Echocardiogr."},{"issue":"14","key":"10.1111\/chd.12564-BIB0066|chd12564-cit-0067","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/hrt.2010.194118","article-title":"Left ventricular myocardial deformation and mechanical dyssynchrony in children with normal ventricular shortening fraction after anthracycline therapy","volume":"96","author":"Cheung","year":"2010","journal-title":"Heart."},{"issue":"3","key":"10.1111\/chd.12564-BIB0067|chd12564-cit-0068","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.amjcard.2010.09.048","article-title":"Left ventricular function assessed by two-dimensional speckle tracking echocardiography in long-term survivors of Hodgkin's lymphoma treated by mediastinal radiotherapy with or without anthracycline therapy","volume":"107","author":"Tsai","year":"2011","journal-title":"Am J Cardiol."},{"key":"10.1111\/chd.12564-BIB0068|chd12564-cit-0069","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1253\/circj.CJ-12-0264","article-title":"Normal range of left ventricular 2-dimensional strain: Japanese Ultrasound Speckle Tracking of the Left Ventricle (JUSTICE) study","volume":"76","author":"Takigiku","year":"2012","journal-title":"Circ J."},{"issue":"11","key":"10.1111\/chd.12564-BIB0069|chd12564-cit-0070","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.echo.2012.08.007","article-title":"Variability of global left ventricular deformation analysis using vendor dependent and independent two-dimensional speckle-tracking software in adults","volume":"25","author":"Risum","year":"2012","journal-title":"J Am Soc Echocardiogr."},{"issue":"8","key":"10.1111\/chd.12564-BIB0070|chd12564-cit-0071","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1007\/s00246-015-1203-8","article-title":"Abnormal myocardial strain indices in children receiving anthracycline chemotherapy","volume":"36","author":"Pignatelli","year":"2015","journal-title":"Pediatr Cardiol."},{"issue":"05","key":"10.1111\/chd.12564-BIB0071|chd12564-cit-0072","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1017\/S1047951113001182","article-title":"Left ventricular strain and strain rates are decreased in children with normal fractional shortening after exposure to anthracycline chemotherapy","volume":"24","author":"Moon","year":"2014","journal-title":"Cardiol Young."},{"issue":"1","key":"10.1111\/chd.12564-BIB0072|chd12564-cit-0073","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0735-1097(92)90138-D","article-title":"Prolongation of isovolumetric relaxation time as assessed by Doppler echocardiography predicts doxorubicin-induced systolic dysfunction in humans","volume":"20","author":"Stoddard","year":"1992","journal-title":"JACC."},{"issue":"10","key":"10.1111\/chd.12564-BIB0073|chd12564-cit-0074","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1136\/hrt.2003.027516","article-title":"Prospective longitudinal assessment of late anthracycline cardiotoxicity after childhood cancer: the role of diastolic function","volume":"90","author":"Dorup","year":"2004","journal-title":"Heart."},{"issue":"11","key":"10.1111\/chd.12564-BIB0074|chd12564-cit-0075","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/MPH.0b013e3181580ea2","article-title":"Late echocardiography assessment of systolic and diastolic function of the left ventricle in pediatric cancer survivors after anthracycline therapy","volume":"29","author":"Santin","year":"2007","journal-title":"J Pediatr Hematol Oncol."},{"issue":"1","key":"10.1111\/chd.12564-BIB0075|chd12564-cit-0076","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/HCO.0000000000000346","article-title":"The continuing challenge of evaluating diastolic function by echocardiography in children: developing concepts and newer modalities","volume":"32","author":"Mawad","year":"2017","journal-title":"Curr Opin Cardiol."},{"issue":"5","key":"10.1111\/chd.12564-BIB0076|chd12564-cit-0077","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S0735-1097(98)90060-2","article-title":"Cardiac tamponade and pericardial effusion: respiratory variation in transvalvular flow velocities studied by Doppler echocardiography","volume":"11","author":"Appleton","year":"1988","journal-title":"J Am Coll Cardiol."},{"issue":"4","key":"10.1111\/chd.12564-BIB0077|chd12564-cit-0078","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3109\/10976640009148691","article-title":"Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance","volume":"2","author":"Bellenger","year":"2000","journal-title":"J Cardiovasc Magn Reson."},{"issue":"3","key":"10.1111\/chd.12564-BIB0078|chd12564-cit-0079","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/00004728-200605000-00013","article-title":"Left ventricular papillary muscle mass: relationship to left ventricular mass and volumes by magnetic resonance imaging","volume":"30","author":"Vogel-Claussen","year":"2006","journal-title":"J Comput Assist Tomogr."},{"issue":"11","key":"10.1111\/chd.12564-BIB0079|chd12564-cit-0080","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.amjcard.2012.07.040","article-title":"Left ventricular mass in patients with a cardiomyopathy after treatment with anthracyclines","volume":"110","author":"Neilan","year":"2012","journal-title":"Am J Cardiol."},{"issue":"8","key":"10.1111\/chd.12564-BIB0080|chd12564-cit-0081","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jcmg.2012.11.017","article-title":"Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease","volume":"6","author":"Drafts","year":"2013","journal-title":"JACC Cardiovasc Imaging."},{"issue":"1","key":"10.1111\/chd.12564-BIB0081|chd12564-cit-0082","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11547-010-0594-0","article-title":"Utility of T2-weighted short-tau inversion recovery (STIR) sequences in cardiac MRI: an overview of clinical applications in ischaemic and non-ischaemic heart disease","volume":"116","author":"Francone","year":"2011","journal-title":"Radiol Med."},{"issue":"1","key":"10.1111\/chd.12564-BIB0082|chd12564-cit-0083","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1161\/CIRCIMAGING.111.967836","article-title":"Improved detection of myocardial involvement in acute inflammatory cardiomyopathies using T2 mapping","volume":"5","author":"Thavendiranathan","year":"2012","journal-title":"Circ Cardiovasc Imaging."},{"issue":"10","key":"10.1111\/chd.12564-BIB0083|chd12564-cit-0084","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1093\/eurheartj\/ehr481","article-title":"Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology","volume":"33","author":"Ugander","year":"2012","journal-title":"Eur Heart J."},{"issue":"22","key":"10.1111\/chd.12564-BIB0084|chd12564-cit-0085","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1161\/01.CIR.0000130926.51766.CC","article-title":"Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy","volume":"109","author":"Cardinale","year":"2004","journal-title":"Circulation."},{"key":"10.1111\/chd.12564-BIB0085|chd12564-cit-0086","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s00277-003-0615-3","article-title":"Prolonged monitoring of troponin T for the detection of anthracycline cardiotoxicity in adults with hematological malignancies","volume":"82","author":"Auner","year":"2003","journal-title":"Ann Hematol."},{"issue":"4","key":"10.1111\/chd.12564-BIB0086|chd12564-cit-0087","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.lab.2005.02.003","article-title":"Monitoring of cardiac function on the basis of serum troponin I levels in patients with acute leukemia treated with anthracyclines","volume":"145","author":"Specchia","year":"2005","journal-title":"Lab Clin Med."},{"issue":"5","key":"10.1111\/chd.12564-BIB0087|chd12564-cit-0088","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/annonc\/mdi152","article-title":"cTnT can be a useful marker for early detection of anthracycline cardiotoxicity","volume":"16","author":"Kilickap","year":"2005","journal-title":"Ann Oncol."},{"issue":"6","key":"10.1111\/chd.12564-BIB0088|chd12564-cit-0089","doi-asserted-by":"crossref","first-page":"S151","DOI":"10.1016\/j.cardfail.2007.06.634","article-title":"Superior detection of cardiotoxicity during chemotherapy using biomarkers","volume":"13","author":"Lenihan","year":"2007","journal-title":"J Card Fail."},{"issue":"11","key":"10.1111\/chd.12564-BIB0089|chd12564-cit-0090","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1038\/bjc.2011.439","article-title":"Serial measurements of NT-proBNP are predictive of not-high-dose anthracycline cardiotoxicity in breast cancer patients","volume":"105","author":"Romano","year":"2011","journal-title":"Br J Cancer."},{"issue":"5","key":"10.1111\/chd.12564-BIB0090|chd12564-cit-0091","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s00392-007-0633-6","article-title":"Usefulness of myocardial performance index and biochemical markers for early detection of anthracycline-induced cardiotoxicity in adults","volume":"97","author":"Dodos","year":"2008","journal-title":"Clin Res Cardiol."},{"issue":"9","key":"10.1111\/chd.12564-BIB0091|chd12564-cit-0092","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.amjcard.2011.01.006","article-title":"Early detection and prediction of cardiotoxicity in chemotherapy treated patients","volume":"107","author":"Sawaya","year":"2011","journal-title":"Am J Cardiol."},{"issue":"10","key":"10.1111\/chd.12564-BIB0092|chd12564-cit-0093","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1200\/JCO.2010.30.3404","article-title":"Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: association with long-term echocardiographic outcomes","volume":"30","author":"Lipshultz","year":"2012","journal-title":"J Clin Oncol."},{"issue":"2","key":"10.1111\/chd.12564-BIB0093|chd12564-cit-0094","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa035153","article-title":"The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia","volume":"351","author":"Lipshultz","year":"2004","journal-title":"N Engl J Med."},{"issue":"10","key":"10.1111\/chd.12564-BIB0094|chd12564-cit-0095","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S1470-2045(10)70204-7","article-title":"Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukemia: long-term follow-up of a prospective, randomized, multi-centre trial","volume":"11","author":"Lipshultz","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1111\/chd.12564-BIB0095|chd12564-cit-0096","first-page":"CD003917","article-title":"Cardioprotective intervention for cancer patients receiving anthracyclines","volume":"6","author":"Dalen","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"24","key":"10.1111\/chd.12564-BIB0096|chd12564-cit-0097","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1200\/JCO.2014.59.4473","article-title":"Late mortality after dexrazoxane treatment: a report from the Children's Oncology Group","volume":"33","author":"Chow","year":"2015","journal-title":"J Clin Oncol."},{"issue":"9","key":"10.1111\/chd.12564-BIB0097|chd12564-cit-0098","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.healun.2014.06.002","article-title":"The international society for heart and lung transplantation guidelines for the management of pediatric heart failure: executive summary","volume":"33","author":"Kirk","year":"2014","journal-title":"J Heart Lung Transplant."},{"issue":"23","key":"10.1111\/chd.12564-BIB0098|chd12564-cit-0099","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1161\/CIRCULATIONAHA.106.635144","article-title":"Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin converting enzyme inhibition","volume":"114","author":"Cardinale","year":"2006","journal-title":"Circulation."},{"issue":"3","key":"10.1111\/chd.12564-BIB0099|chd12564-cit-0100","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jacc.2009.03.095","article-title":"Anthracycline-induced cardiomyopathy","volume":"55","author":"Cardinale","year":"2010","journal-title":"JACC."},{"issue":"23","key":"10.1111\/chd.12564-BIB0100|chd12564-cit-0101","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1016\/j.jacc.2013.02.072","article-title":"Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies","volume":"61","author":"Bosch","year":"2013","journal-title":"JACC."},{"issue":"5","key":"10.1111\/chd.12564-BIB0101|chd12564-cit-0102","doi-asserted-by":"crossref","first-page":"509","DOI":"10.5603\/CJ.a2013.0150","article-title":"Effect of carvedilol on silent anthracycline-induced cardiomyopathy assessed by strain imaging: a prospective randomized controlled study with six-month follow-up","volume":"21","author":"Elitok","year":"2014","journal-title":"Cardiol J."},{"issue":"23","key":"10.1111\/chd.12564-BIB0102|chd12564-cit-0103","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1200\/JCO.2002.12.102","article-title":"Long-term enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood cancer","volume":"20","author":"Lipshultz","year":"2002","journal-title":"J Clin Oncol."},{"issue":"8","key":"10.1111\/chd.12564-BIB0103|chd12564-cit-0104","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.cardfail.2012.06.416","article-title":"Protective effect of carvedilol on adriamycin-induced left ventricular dysfunction in children with acute lymphoblastic leukemia","volume":"18","author":"El-Shitany","year":"2012","journal-title":"J Card Fail."},{"issue":"5","key":"10.1111\/chd.12564-BIB0104|chd12564-cit-0105","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1200\/JCO.2004.06.022","article-title":"Enalapril to prevent cardiac function decline in long-term survivors of pediatric cancer exposed to anthracyclines","volume":"22","author":"Silber","year":"2004","journal-title":"J Clin Oncol."},{"key":"10.1111\/chd.12564-BIB0105|chd12564-cit-0106","first-page":"273","article-title":"AHA\/ACC scientific statement eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities and other cardiomyopathies, and myocarditis","volume":"66","author":"Maron","year":"2015","journal-title":"JACC."},{"issue":"8","key":"10.1111\/chd.12564-BIB0106|chd12564-cit-0107","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.healun.2012.03.018","article-title":"Characteristicss and survival of patients with chemotherapy-induced cardiomyopathy undergoing heart transplantation","volume":"31","author":"Oliveira","year":"2012","journal-title":"J Heart Lung Transplant."},{"issue":"3","key":"10.1111\/chd.12564-BIB0107|chd12564-cit-0108","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jacc.2013.09.040","article-title":"Increased need for right ventricular support in patients with chemotherapy-induced cardiomyopathy undergoing mechanical circulatory support: outcomes from the INTERMACS Registry","volume":"63","author":"Oliveira","year":"2014","journal-title":"JACC."},{"key":"10.1111\/chd.12564-BIB0108|chd12564-cit-0109","doi-asserted-by":"crossref","first-page":"e12923","DOI":"10.1111\/petr.12923","article-title":"Cancer recurrence and mortality after pediatric heart transplantation for anthracycline cardiomyopathy: a report from the Pediatric Heart Transplant Study (PHTS) group","volume":"21","author":"Bock","year":"2017","journal-title":"Pediatr Transplant."},{"issue":"5","key":"10.1111\/chd.12564-BIB0109|chd12564-cit-0110","doi-asserted-by":"crossref","first-page":"e12946","DOI":"10.1111\/petr.12946","article-title":"Heart transplantation for anthracycline cardiomyopathy: pump up the volume","volume":"21","author":"Meister","year":"2017","journal-title":"Pediatr Transplant."},{"issue":"3","key":"10.1111\/chd.12564-BIB0110|chd12564-cit-0111","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/bcp.13120","article-title":"Prevention of cardiotoxicity among survivors of childhood cancer","volume":"83","author":"Hutchins","year":"2017","journal-title":"Br J Clin Pharmacol."}],"container-title":["Congenital Heart Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fchd.12564","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.techscience.com\/uploads\/attached\/file\/20200508\/20200508071446_95069.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T18:24:27Z","timestamp":1733509467000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.techscience.com\/chd\/v13n1\/38956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,11]]},"references-count":110,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"URL":"https:\/\/doi.org\/10.1111\/chd.12564","archive":["Portico"],"relation":{},"ISSN":["1747-079X"],"issn-type":[{"type":"print","value":"1747-079X"}],"subject":[],"published":{"date-parts":[[2017,12,11]]}}}